Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

AstraZeneca’s Imfinzi regimen receives EC approval to treat resectable NSCLC

More than 450,000 people are diagnosed with lung cancer every year in Europe

- PMLiVE

J&J’s Stelara granted EC approval to treat Crohn’s disease in paediatric patients

Approximately 25% of cases are diagnosed during childhood or adolescence

- PMLiVE

The AI advantage: seven steps to augmented pharma brand planning

By strategically leveraging AI, teams can work smarter and more efficiently

- PMLiVE

From Noise to Impact: Why Simplicity Is The Health Communicator’s Most Powerful Tool

Clear health communication has never been more critical, as shown by the 2025 surge in ADHD self-diagnoses in the UK, driven by misleading social media content. In a noisy, fast-paced...

Fox&Cat

- PMLiVE

Amgen’s Uplizna approved by FDA as first treatment for rare disease IgG4-RD

Immunoglobulin G4-related disease affects approximately 20,000 people in the US

- PMLiVE

Novartis’ Vanrafia granted FDA approval for rare kidney disease IgA nephropathy

Almost 13 out of every million people in the US are diagnosed with IgAN each year

- PMLiVE

AstraZeneca/Daiichi Sankyo’s Enhertu receives EC approval for HER2-low breast cancer

Approximately 557,000 people are diagnosed with breast cancer every year in Europe

- PMLiVE

The importance of the human touch in today’s AI world

The robots aren’t taking over – but they do have the potential to elevate our profession

- PMLiVE

Top-10 Best Practices for Virtual Publication Planning and Development

Virtual publication planning is rapidly evolving with new digital tools, but are you truly optimizing your strategy? Our article dives into the challenges of this new landscape, from data security...

Impetus Digital

- PMLiVE

Medscape at ESCMID 2025: Advancing Infectious Disease Education

Medscape, a global leader in infectious disease education, continues its commitment to advancing knowledge in the field. With 1.47 million ID learners in 2024, the Medscape team will travel to...

Medscape Education

EU flag

Genmab announces EC approval of Tivdak in recurrent or metastatic cervical cancer

Approximately 660,000 new cases of the disease were diagnosed globally in 2022 alone

- PMLiVE

Takeda receives NICE recommendation for Adcetris combination in Hodgkin lymphoma

Around 800 people in the UK are diagnosed with late-stage disease every year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links